Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis.

Genes - 11 May 2020

Lanznaster Débora, Veyrat-Durebex Charlotte, Vourc'h Patrick, Andres Christian R, Blasco Hélène, Corcia Philippe

Abstract excerpt

Metabolomics studies performed in patients with amyotrophic lateral sclerosis (ALS) reveal a set of distinct metabolites that can shed light on the pathological alterations taking place in each individual. Metabolites levels are influenced by disease status, and genetics play an important role both in familial and sporadic ALS cases. Metabolomics analysis helps to unravel the differential impact of the most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to C9orf72 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Induced Pluripotent Stem Cells

Share to Metabolomics

Share to Precision Medicine

Share to RNA-Binding Protein FUS

Share to Superoxide Dismutase-1

Source

Open in PubMed Open full text

Identifiers

PMID: 32403313
DOI: 10.3390/genes11050537
PMCID: PMC7288444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis.PMID 32403313Read ↗

Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms.Semantic proximity Read ↗

Biomarkers for amyotrophic lateral sclerosis.Semantic proximity Read ↗

Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.Semantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Abnormal energy metabolism in ALS: a key player?Semantic proximity Read ↗

Integrated Multi-Omic Data Analysis and Validation with Yeast Model Show Oxidative Phosphorylation Modulate Protein Aggregation in Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosisSemantic proximity Read ↗

Gene Expression Profiles in Sporadic ALS Fibroblasts Define Disease Subtypes and The Metabolic Effects of the Investigational Drug EH301Semantic proximity Read ↗

Identification of a Distinct Metabolomic Subtype of Sporadic ALS PatientsSemantic proximity Read ↗

Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis DiagnosisSemantic proximity Read ↗

Causal effects of serum metabolites on amyotrophic lateral sclerosis: A Mendelian randomization study.Semantic proximity Read ↗

Recent advances in the application of metabolomics to Alzheimer's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.